Intraocular pressure reduction in glaucoma: Does every mmHg count?

被引：32

作者：

Jayaram, Hari ^{[1
,2
,3
]}

机构：

[1] Moorfields Eye Hosp NHS Fdn Trust, Glaucoma Serv, London, England

[2] UCL Inst Ophthalmol, London, England

[3] NIHR Moorfields Biomed Res Ctr, London, England

来源：

TAIWAN JOURNAL OF OPHTHALMOLOGY | 2020年 / 10卷 / 04期

关键词：

Glaucoma; Intraocular Pressure; Rate of Progression; OCULAR-HYPERTENSION-TREATMENT; PROGRESSION; PREVALENCE; ONSET; RATES;

D O I：

10.4103/tjo.tjo_63_20

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

The reduction of intraocular pressure is currently the only known modifiable risk factor for the treatment of Glaucoma, which is the leading cause of irreversible worldwide blindness. This concise review discusses the evidence underpinning the reduction of intraocular pressure in the treatment of glaucoma, the role of target intraocular pressure in clinical practice and appraises clinical data supporting the concept that every mmHg of intraocular pressure reduction is important in reducing the risk of developing glaucoma and the progression of existing disease. Every mmHg in IOP reduction is important, with evidence showing an impact on both functional and structural progression but does not however explain all glaucoma risk.

引用

页码：255 / 258

页数：4

共 22 条

[1]

Allergan, SAV SIGHT YEARS ENG

[2]

[Anonymous], 2017, Br J Ophthalmol, V101, P130, DOI 10.1136/bjophthalmol-2016-EGSguideline.003

[3] Change in Visual Field Progression Following Treatment Escalation in Primary Open-angle Glaucoma [J].

Aptel, Florent ;

Bron, Alain M. ;

Lachkar, Yves ;

Schweitzer, Cedric .

JOURNAL OF GLAUCOMA, 2017, 26 (10) :875-880

[4] A Critical Discussion of the Rates of Progression and Causes of Optic Nerve Damage in Glaucoma: International Glaucoma Think Tank II: July 25-26, 2008, Florence, Italy [J].

Caprioli, Joseph ;

Zeyen, Thierry .

JOURNAL OF GLAUCOMA, 2009, 18 (06) :S1-S21

[5] Canadian glaucoma study - 2. Risk factors for the progression of open-angle glaucoma [J].

Chauhan, Balwantray C. ;

Mikelberg, Frederick S. ;

Balaszi, A. Gordon ;

LeBlanc, Raymond P. ;

Lesk, Mark R. ;

Trope, Graham E. .

ARCHIVES OF OPHTHALMOLOGY, 2008, 126 (08) :1030-1036

[6] Lower Corneal Hysteresis is Associated With More Rapid Glaucomatous Visual Field Progression [J].

De Moraes, Carlos Gustavo V. ;

Hill, Victoria ;

Tello, Celso ;

Liebmann, Jeffrey M. ;

Ritch, Robert .

JOURNAL OF GLAUCOMA, 2012, 21 (04) :209-213

[7] Association between Intraocular Pressure and Rates of Retinal Nerve Fiber Layer Loss Measured by Optical Coherence Tomography [J].

Diniz-Filho, Alberto ;

Abe, Ricardo Y. ;

Zangwill, Linda M. ;

Gracitelli, Carolina P. B. ;

Weinreb, Robert N. ;

Girkin, Christopher A. ;

Liebmann, Jeffrey M. ;

Medeiros, Felipe A. .

OPHTHALMOLOGY, 2016, 123 (10) :2058-2065

[8] Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial [J].

Garway-Heath, David F. ;

Crabb, David P. ;

Bunce, Catey ;

Lascaratos, Gerassimos ;

Amalfitano, Francesca ;

Anand, Nitin ;

Azuara-Blanco, Augusto ;

Bourne, Rupert R. ;

Broadway, David C. ;

Cunliffe, Ian A. ;

Diamond, Jeremy P. ;

Fraser, Scott G. ;

Ho, Tuan A. ;

Martin, Keith R. ;

McNaught, Andrew I. ;

Negi, Anil ;

Patel, Krishna ;

Russell, Richard A. ;

Shah, Ameet ;

Spry, Paul G. ;

Suzuki, Katsuyoshi ;

White, Edward T. ;

Wormald, Richard P. ;

Xing, Wen ;

Zeyen, Thierry G. .

LANCET, 2015, 385 (9975) :1295-1304

[9]

Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714

[10] Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial [J].

Heijl, A ;

Leske, MC ;

Bengtsson, B ;

Hyman, L ;

Bengtsson, B ;

Hussein, M .

ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (10) :1268-1279

← 1 2 3 →